Overview

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid